🔎 Trials Near Me

Početna › Sarkom mekih tkiva › Massachusetts › Boston

Kliničke studije za Sarkom mekih tkiva u gradu Boston, MA

18 studija za Sarkom mekih tkiva traži sudionike na lokacijama u gradu Boston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Distance-Based Exercise to Preserve Function and Prevent Disability

U tijeku regrutacija
  • Dana-Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07059884

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

U tijeku regrutacijaFaza 2
  • Dana-Farber Cancer Institute - Oncology Department, Boston
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06760819

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

U tijeku regrutacijaFaza 1/2
  • Dana Farber Cancer Institute., Boston
Do 25 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT04094610

Anti-GD2 ADC M3554 in Advanced Solid Tumors

U tijeku regrutacijaFaza 1
  • Dana-Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT06641908

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

U tijeku regrutacijaFaza 1/2
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT05732831

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

U tijeku regrutacijaFaza 1
  • Dana-Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06644755

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

U tijeku regrutacijaFaza 1
  • Dana-Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT05711615

Serial MRI Scans During Radiation Therapy

U tijeku regrutacija
  • Brigham and Women Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT04188535

Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention

U tijeku regrutacija
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Od 15 do 39 godina · Oba spola · Ažurirano 26. kol 2026. · NCT07662239

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

U tijeku regrutacijaFaza 1/2
  • Dana Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 25. kol 2026. · NCT06975293

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

U tijeku regrutacijaFaza 1/2
  • Dana Farber Cancer Institute, Boston
Do 30 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06239272

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

U tijeku regrutacijaOpažajna studija
  • Brigham and Women's Hospital, Boston
Od 18 godina i više · Oba spola · Ažurirano 15. srp 2026. · NCT07377747

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

U tijeku regrutacijaOpažajna studija
  • Dana-Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 30. lip 2026. · NCT07675967

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

U tijeku regrutacijaFaza 1/2
  • Massachusetts General Hospital,, Boston
Od 12 godina i više · Oba spola · Ažurirano 27. svi 2026. · NCT03093116

Video Education With Result Dependent dIsclosure

U tijeku regrutacija
  • Dana Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 22. svi 2026. · NCT05225428

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

U tijeku regrutacijaFaza 1/2
  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Brigham and Women's Hospital, Boston
Od 12 do 49 godina · Oba spola · Ažurirano 19. velj 2026. · NCT06709495

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

U tijeku regrutacijaFaza 1/2
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 8. lis 2025. · NCT04370587

REtroperitoneal SArcoma Registry: an International Prospective Initiative

U tijeku regrutacijaOpažajna studija
  • Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 12. velj 2019. · NCT03838718

Studije za Sarkom mekih tkiva u drugim gradovima

Ostale studije u gradu Boston

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.